Immediate Impact
51 standout
Citing Papers
Counts, incidence rates, and trends of pediatric cancer in the United States, 2003-2019
2023 Standout
Biodegradable NIR‐II Pseudo Conjugate Polymeric Nanoparticles Amplify Photodynamic Immunotherapy via Alleviation of Tumor Hypoxia and Tumor‐Associated Macrophage Reprogramming
2023 Standout
Works of Mason Bond being referenced
A phase II study of imatinib mesylate in children with refractory or relapsed solid tumors: A Children's Oncology Group study
2007
Understanding clinical trials in childhood cancer
2006
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Mason Bond | 97 | 194 | 98 | 123 | 121 | 15 | 502 | |
| Yacov Goshen | 118 | 123 | 56 | 161 | 87 | 18 | 433 | |
| Andy Gillespie | 206 | 212 | 33 | 91 | 149 | 13 | 456 | |
| Byung-Kiu Park | 43 | 78 | 84 | 115 | 120 | 27 | 478 | |
| Louis Munoz | 135 | 150 | 91 | 54 | 80 | 13 | 492 | |
| T. Holbrook | 251 | 190 | 52 | 183 | 135 | 13 | 547 | |
| Linda Hershon | 105 | 142 | 26 | 118 | 124 | 15 | 430 | |
| Michael J. Warzynski | 40 | 90 | 68 | 46 | 144 | 23 | 456 | |
| Federico Sackmann Muriel | 71 | 135 | 102 | 42 | 143 | 21 | 436 | |
| Kenneth M. Griffith | 27 | 190 | 197 | 141 | 184 | 10 | 467 | |
| M.C. Demaille | 123 | 235 | 19 | 117 | 97 | 20 | 487 |
All Works
Loading papers...